VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_15-vv-00091
Package ID: USCOURTS-cofc-1_15-vv-00091
Petitioner: J.D.B.
Filed: 2015-01-29
Decided: 2016-07-13
Vaccine: DTaP
Vaccination date: 2012-01-27
Condition: idiopathic thrombocytopenic purpura (ITP)
Outcome: compensated
Award amount USD: 110000

AI-assisted case summary:
On January 29, 2015, James Bojan filed a petition on behalf of his minor child, J.D.B., under the National Vaccine Injury Compensation Program. The petition alleged that a diphtheria-tetanus-acellular pertussis (DTaP) vaccination administered on January 27, 2012, either caused or significantly aggravated J.D.B.'s idiopathic thrombocytopenic purpura (ITP). The respondent, the Secretary of Health and Human Services, denied that the DTaP immunization caused or aggravated J.D.B.'s condition or any other injury. The parties reached a settlement agreement, which was filed on July 13, 2016. As part of the settlement, the respondent agreed to issue a lump sum payment of $110,000.00, payable to James Bojan as guardian/conservator of the estate of J.D.B., for the benefit of J.D.B. This payment represents compensation for all damages available under the program. Special Master Mindy Michaels Roth adopted the parties' stipulation and awarded the compensation. The decision does not describe the specific onset of symptoms, clinical details of J.D.B.'s condition, diagnostic tests, treatments, or the specific mechanism by which the vaccine allegedly caused or aggravated the ITP. Petitioner's counsel was Mark L. Krueger of Krueger & Hernandez, S.C., and respondent's counsel was Glenn MacLeod of the U.S. Department of Justice.

Theory of causation field:
Petitioner alleged that a DTaP vaccination on January 27, 2012, caused or significantly aggravated J.D.B.'s idiopathic thrombocytopenic purpura (ITP). Respondent denied this allegation. The parties reached a settlement, agreeing to compensation. The public decision does not detail the specific theory of causation, medical experts, clinical evidence, or the mechanism linking the DTaP vaccine to ITP. The settlement resulted in an award of $110,000.00. Special Master Mindy Michaels Roth adopted the stipulation. The decision was issued on July 13, 2016. Petitioner's counsel was Mark L. Krueger, and respondent's counsel was Glenn MacLeod.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_15-vv-00091-0
Date issued/filed: 2016-08-19
Pages: 8
Docket text: PUBLIC DECISION (Originally filed: 7/13/2016) regarding 34 DECISION Stipulation/Proffer. Signed by Special Master Mindy Michaels Roth. (jdm) Copy to parties.
--------------------------------------------------------------------------------
Case 1:15-vv-00091-UNJ Document 37 Filed 08/19/16 Page 1 of 8
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
(Filed: July 13, 2016)
No. 15-91V
* * * * * * * * * * * * * UNPUBLISHED
JAMES BOJAN as parent of *
J.D.B., * Decision on Joint Stipulation;
* Idiopathic Thrombocytopenic
Petitioners, * Purpura (“ITP”); Diphtheria-
* Tetanus- acellular Pertussis
v. * (“DTaP”) vaccine.
*
SECRETARY OF HEALTH *
AND HUMAN SERVICES, *
*
Respondent. *
*
* * * * * * * * * * * * *
Mark L. Krueger, Krueger & Hernandez, S.C., Baraboo, WI, for petitioner.
Glenn MacLeod, US Department of Justice, Washington, DC, for respondent.
DECISION ON JOINT STIPULATION1
Roth, Special Master:
On January 29, 2015, James Bojan (“petitioner”) filed a petition for compensation on
behalf of his minor child, J.D.B, under the National Vaccine Injury Compensation Program.2
Petitioner alleges that a diphtheria-tetanus-acellular pertussis (“DTaP”) vaccination J.D.B
received on January 27, 2012 either caused or significantly aggravated his idiopathic
thrombocytopenic purpura (“ITP”). See Stipulation, filed July 13, 2016, at 1-6. Respondent
denies that the DTaP immunization caused or significantly aggravated J.D.B.’s condition or any
other injury. Stipulation at 2.
1 Because this unpublished decision contains a reasoned explanation for the action in this case, I intend to post this
decision on the United States Court of Federal Claims' website, in accordance with the E-Government Act of 2002,
Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). In
accordance with Vaccine Rule 18(b), a party has 14 days to identify and move to delete medical or other
information, that satisfies the criteria in 42 U.S.C. § 300aa-12(d)(4)(B). Further, consistent with the rule
requirement, a motion for redaction must include a proposed redacted decision. If, upon review, I agree that the
identified material fits within the requirements of that provision, I will delete such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of
citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012).
1

Case 1:15-vv-00091-UNJ Document 37 Filed 08/19/16 Page 2 of 8
Nevertheless, the parties have agreed to settle the case. On July 13, 2016, the parties
filed a joint stipulation, attached as Appendix A, agreeing to settle this case and describing the
settlement terms.
Respondent agrees to issue the following payment:
A lump sum of $110,000.00 in the form of a check payable to petitioner, James
Bojan, as guardian/conservator of the estate of J.D.B. for the benefit of J.D.B.,
representing compensation for all damages that would be available under § 300aa-
15(a).
I adopt the parties’ stipulation attached hereto, and award compensation in the amount
and on the terms set forth therein. The clerk of the court is directed to enter judgment in
accordance with this decision.3
IT IS SO ORDERED.
s/ Mindy Michaels Roth
Mindy Michaels Roth
Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party filing a notice renouncing the
right to seek review.
2

Case 1:15-vv-00091-UNJ Document 37 Filed 08/19/16 Page 3 of 8

Case 1:15-vv-00091-UNJ Document 37 Filed 08/19/16 Page 4 of 8

Case 1:15-vv-00091-UNJ Document 37 Filed 08/19/16 Page 5 of 8

Case 1:15-vv-00091-UNJ Document 37 Filed 08/19/16 Page 6 of 8

Case 1:15-vv-00091-UNJ Document 37 Filed 08/19/16 Page 7 of 8

Case 1:15-vv-00091-UNJ Document 37 Filed 08/19/16 Page 8 of 8